Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: https://t.co/3625asvzu8
⚡️Fresh off the Press #Europace
Long-term outcomes among immigrants and non-immigrants in cardiac resynchronization therapy. #CRT Insight from 🇩🇰Danish nationwide registries.
🧐👉https://t.co/HaXmV7s8ds
@GiulioConte9 @marcovitoloMD@FraSantoroMD@Dominik_Linz@AndyZhangMD
📢Exciting research by Krøll et al. in @ESC_Journals reveals that CRT demonstrates comparable effectiveness in improving #HF outcomes among immigrants and non-immigrants. However, immigrants received CRT at a significantly younger age, yet both groups had equal mortality rates🫀
Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study
👉 https://t.co/vp8lMt7VSr
@Dominik_Linz @GiulioConte9 @FraSantoroMD@marcovitoloMD@AndyZhangMD
Happy to announce that our study on disease manifestation and development of depression/anxiety in pts with #BrugadaSyndrome is out now in #Europace
https://t.co/R3apkythkV
@JacobTfelt@weekepe
The findings of the present registry-based study by dr. @lmaltaw suggest that a lenient rate control approach aimed lower than recommended by current guidelines and is associated with better outcomes ☠️ among rate-control treated patients presenting with atrial fibrillation🫀
Medical student @Gylling123 presenting his research for the first time at this years @EHRA2023 in #Barcelona🇪🇸🫀supervised by prof. @JacobTfelt and dr. @weekepe 👏🏻👏🏻
📢 Patients with BrS are recommended to avoid drugs that increases their risk of arrhythmic events. But what does the follow up really show??
Don't miss this GREAT work by @CamJespersen 👌
So happy to be a part of this!
@weekepe@JacobTfelt@bowinkel75
https://t.co/lYmJjttO7I